NCT06303648

A Single, Ascending Dose Evaluation of the Safety, Pharmacokinetics of Methylone in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Transcend Therapeutics · Industry
• Sex: All
• Age: 25 Years – 55 Years
• Healthy volunteers: Accepted

Summary

This is an open-label, single, ascending dose study evaluating the PK and safety of methylone in healthy subjects.

Conditions

• Post Traumatic Stress Disorder

Interventions

Type	Name	Description
DRUG	Methylone	Oral dose of methylone
DRUG	Placebo	Placebo to match methylone

Timeline

• Start date: 2024-03-20
• Primary completion: 2025-07-13
• Completion: 2025-07-13
• First posted: 2024-03-12
• Last updated: 2025-09-09

Locations

1 site across 1 country: Australia

Regulatory

• FDA-regulated drug study